The present investigations were undertaken to study the effect of in vivo administration of FK565 on the process of hemopoiesis in normal and tumor-bearing mice. FK565 administration (10 mg/kg body weight) of normal mice resulted in an enhancement of the bone marrow cell (BMC) colony foming activity (CFA) and proliferation in vitro. The counts of granulocyte- and granulocyte macrophage-colony forming units (CFU-G and CFU-GM) were significantly enhanced in the BMC of FK565-treated group. The total leukocyte count (TLC) was also augmented after FK565 administration. The differential leukocyte count (DLC) revealed an enhancement of the neutrophil count in the FK565-treated mice. A similar pattern of BMC proliferation, CFA, TLC and DLC was observed in P815 tumor-bearing mice. FK565 administration of the tumor-bearing mice, however, did not significantly alter the CFA, TLC and DLC.
TalmadgeJ.E.LenzB.SchneiderM.PhillipsH.LongC., 1989. Immunomodulatory and therapeutic properties of FK565 in Mice. Cancer Immunol. Immunother.28:93.
2.
BasuS.SodhiA.SinghS.M.SureshA., 1991. Up-regulation of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin. Immunology Letters. 27:199.
3.
InamuraN.SoneS.OkuboA.KunishigeE.NakanisihiM.OguraT., 1989. Tumor cytotoxicity of human monocyte membrane-bound interleukin-1α induced by synergistic actions of interferon-γ and synthetic acryltripeptide, FK565. Cancer Immunol. Immunother.28:164.
4.
ParajuliP.SinghS.M.KumarA., 1995. Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's Lymphoma. Int. J. Immunopharmacol.17:1.
5.
Szuro-SudolA.MurrayH.W.NathanC.F., 1983. Suppression of macrophage antimicrobial activity by a tumor cell product. J. Immunol.131:384.
6.
HasdayJ.D.ShahE.M.LiebermanA.P., 1990. Macrophage tumor necrosis factor release is induced by contact with some tumors. J. Immunol.145:371.
7.
SotomayorE.M.FuY-X.Lopez-CeperoM., 1991. Tumor cells produce GM-CSF which inhibit macrophage mediated tumor cytotoxicity. J. Immunol.147:2816.
8.
FuY-X.WatsonG.A.KasaharaM.LopezD.M., 1991. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J. Immunol.146:783.
9.
FauveR.M.1993. Some aspects of the macrophage cancer relationship. Res. Immunol.144:265.
10.
CiancioloG.J.1993. Antiinflammatory effects of neoplasms. Res. Immunol.144:268.
11.
KumarA.SinghS.M.ParajuliP., 1994. Modulatory effect of Dalton's Lymphoma cells on the production of reactive nitrogen intermediates, interleukin-1 and tumor necrosis factor by murine peritonal macrophages. Neoplasma. 41:363.
12.
DegowinR.L.GibsonD.P., 1978. Suppressive effect of an extramedullary tumor on bone marrow erythropoiesis and stroma. Exp. Hematol.6:568.
13.
LeeM.Y.LottsfeldtJ.L., 1984. Augmentation of neutrophilic granulocyte progenitors in the bone marrow of mice with tumor-induced neutrophilia: Cytochemical study of in vitro colonies. Blood. 64:499.
14.
HardyC.L.BalducciL., 1985. Review: Hemopoietic alteration of cancer. Am. J. Med. Sci.290:196.
15.
WaheedA.ShadduckR.K., 1979. Purification and properties of L-cell derived colony stimulating factor. J. Lab. Clin. Med.94:180.
16.
HosoeS.OguraT.HayashiS.KomutaK.IkedaT.ShirasakaT.KawaseI.MasunoT.KishimotoS., 1989. Induction of tumoricidal macrophags from bone marrow cells of normal mice bearing a colony-stimulating factor-producing tumor. Cancer Immunol. Immunother.28:116.
17.
SureshA.SodhiA.SinghS.M.BasuS., 1991. In vitro activation of bone marrow-derived macrophages with cisplatin and mitomycin-c. Int. J. Immunopharmacol.13:189.
18.
KumarR.SodhiA.SinghS.M., 1993. Effect of in vivo administration of cisplatin on the colony forming ability of murine bone marrow cells. Int. J. Immunopharmacol.15:281.
19.
SinghS.M.SoneS.InamuraN.OguraT., 1989. Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) on induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes. Int. J. Cancer.44:170.
20.
BroxmeyerH.E.RubinB.Y.CooperS.LuL.WilliamsD.E., 1985. The suppressive influence of human TNF on normal human bone marrow hemopoietic progenitor cells in vitro is synergistic with the effect of human gamma interferon. Blood66:146.
21.
MochizukiD.Y.EisenmanJ.R.ConlonE.J.LarsenA.D.TushinskiR.J., 1987. Interleukin-1 regulates hematopoietic activity: A role previously ascribed to hematopoietin-1. Proc. Natl. Acad. Sci. USA.84:5267.
22.
GuilbertL.J.Winker-LowenB.SmithA.BranchD.R.Lloret-GarciaM., 1993. Analysis of synergistic stimulation of mouse macrophage proliferation by macrophage-colony stimulating factor (CSF-1) and tumor necrosis factor-α (TNF-α). J. Leuk. Biol.54:65.
23.
PessinaA.NeriM.G.BrambillaM.P.MarocchiA.MocarelliP., 1986. Colony stimulating factors produced by murine adenocortical tumor cells. J. Nat. Cancer Inst. 76:1095.
24.
TsuchiyaY.IgarashiM.SuzukiR.KumagaiK., 1988. Production of colony stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J. Immunol.141:699.
25.
SotomayorE.M.FuY-X.Lopz-CeperoM.HerbertL.JimenezJ.J.AlbarracinC.LopezD.M., 1991. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. J. Immunol.147:2816.
26.
LahmH.JosianW.SylvieH.AysinY.JurgenR.F.Jean-ClaudeG.NicolasO., 1994. Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res. 54:3700.
